DNc01 (R), n=2 cell(s)

Main group: Other; Neurotransmitter consensus prediction: unclear

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 10.5 2.0 4.0 13.0 22.0 33.0 5.5 4.0 6.0 9.5 109.5
1 38.0 - 7.5 36.0 53.0 48.5 5.5 2.0 14.5 35.5 240.5
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post 13.0 16.0 1.5 - - - - 30.5
Pre 54.5 28.0 - - - - - 82.5
  AME
0 1
1 2
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 919.0
1 542.5

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 219

Number of pre synapses: 481

Number of output connections: 812

Coverage factor: 1.0

Columnar completeness: 0.39

Area completeness: 0.95

Cell size (columns): 176

Lobula

Number of post synapses: 61

Number of pre synapses: 165

Number of output connections: 330

Coverage factor: 1.0

Columnar completeness: 0.14

Area completeness: 0.63

Cell size (columns): 126

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#DNc01 (R) % % cumu.
0 Cm7 (R) Glu 24 12.0 8.6% 8.6%
1 Tm3 (R) ACh 18 9.0 6.5% 15.1%
2 L5 (R) ACh 13 6.5 4.7% 19.8%
3 Tm1 (R) ACh 11 5.5 4.0% 23.7%
4 Mi1 (R) ACh 9 4.5 3.2% 27.0%
5 Tm2 (R) ACh 9 4.5 3.2% 30.2%
6 Tm4 (R) ACh 9 4.5 3.2% 33.5%
7 Cm17 (R) GABA 7 3.5 2.5% 36.0%
8 Dm2 (R) ACh 7 3.5 2.5% 38.5%
9 Mi10 (R) ACh 7 3.5 2.5% 41.0%
10 Dm10 (R) GABA 5 2.5 1.8% 42.8%
11 Dm8a (R) Glu 5 2.5 1.8% 44.6%
12 MeVPMe2 (R) Glu 5 2.5 1.8% 46.4%
13 Mi15 (R) ACh 5 2.5 1.8% 48.2%
14 Mi2 (R) Glu 5 2.5 1.8% 50.0%
15 Mi20 (R) Glu 5 2.5 1.8% 51.8%
16 TmY19a (R) GABA 5 2.5 1.8% 53.6%
17 Cm31a (R) GABA 4 2.0 1.4% 55.0%
18 LT33 (L) GABA 4 2.0 1.4% 56.5%
19 Pm2a (R) GABA 4 2.0 1.4% 57.9%
20 Tm23 (R) GABA 4 2.0 1.4% 59.4%
21 Am1 (R) GABA 3 1.5 1.1% 60.4%
22 Cm2 (R) ACh 3 1.5 1.1% 61.5%
23 Dm8b (R) Glu 3 1.5 1.1% 62.6%
24 MeLo1 (R) ACh 3 1.5 1.1% 63.7%
25 MeVC22 (R) Glu 3 1.5 1.1% 64.7%
26 MeVPLo2 (R) ACh 3 1.5 1.1% 65.8%
27 Mi16 (R) GABA 3 1.5 1.1% 66.9%
28 Mi19 (R) 5HT 3 1.5 1.1% 68.0%
29 Mi4 (R) GABA 3 1.5 1.1% 69.1%
30 OA-AL2i3 (R) OA 3 1.5 1.1% 70.1%
31 T2 (R) ACh 3 1.5 1.1% 71.2%
32 TmY15 (R) GABA 3 1.5 1.1% 72.3%
33 aMe17e (R) Glu 2 1.0 0.7% 73.0%
34 Ascending_TBD1 (R) unclear 2 1.0 0.7% 73.7%
35 Cm1 (R) ACh 2 1.0 0.7% 74.5%
36 Cm11b (R) ACh 2 1.0 0.7% 75.2%
37 Cm9 (R) Glu 2 1.0 0.7% 75.9%
38 Dm11 (R) Glu 2 1.0 0.7% 76.6%
39 Dm17 (R) Glu 2 1.0 0.7% 77.3%
40 Li17 (R) GABA 2 1.0 0.7% 78.1%
41 MeVP8 (R) ACh 2 1.0 0.7% 78.8%
42 OA-AL2i2 (R) OA 2 1.0 0.7% 79.5%
43 Pm10 (R) GABA 2 1.0 0.7% 80.2%
44 Pm11 (R) GABA 2 1.0 0.7% 80.9%
45 Pm9 (R) GABA 2 1.0 0.7% 81.7%
46 R7d (R) His 2 1.0 0.7% 82.4%
47 T5a (R) ACh 2 1.0 0.7% 83.1%
48 T5b (R) ACh 2 1.0 0.7% 83.8%
49 Tm5c (R) Glu 2 1.0 0.7% 84.5%
50 TmY18 (R) ACh 2 1.0 0.7% 85.3%
51 TmY3 (R) ACh 2 1.0 0.7% 86.0%

Outputs

  instance NT total connections connections /#DNc01 (R) % % cumu.
0 LT33 (L) GABA 91 45.5 7.3% 7.3%
1 Dm10 (R) GABA 85 42.5 6.8% 14.2%
2 TmY3 (R) ACh 54 27.0 4.3% 18.5%
3 Tm3 (R) ACh 48 24.0 3.9% 22.4%
4 Pm11 (R) GABA 45 22.5 3.6% 26.0%
5 T5c (R) ACh 38 19.0 3.1% 29.0%
6 T5b (R) ACh 35 17.5 2.8% 31.9%
7 TmY19a (R) GABA 35 17.5 2.8% 34.7%
8 Lawf1 (R) ACh 29 14.5 2.3% 37.0%
9 T5a (R) ACh 27 13.5 2.2% 39.2%
10 Tm1 (R) ACh 23 11.5 1.9% 41.0%
11 Mi15 (R) ACh 22 11.0 1.8% 42.8%
12 T2 (R) ACh 22 11.0 1.8% 44.6%
13 TmY18 (R) ACh 22 11.0 1.8% 46.3%
14 T5d (R) ACh 21 10.5 1.7% 48.0%
15 T4b (R) ACh 18 9.0 1.4% 49.5%
16 CT1 (L) GABA 17 8.5 1.4% 50.8%
17 Mi4 (R) GABA 16 8.0 1.3% 52.1%
18 Dm2 (R) ACh 14 7.0 1.1% 53.3%
19 L5 (R) ACh 14 7.0 1.1% 54.4%
20 Mi14 (R) Glu 13 6.5 1.0% 55.4%
21 T4c (R) ACh 13 6.5 1.0% 56.5%
22 Tm4 (R) ACh 13 6.5 1.0% 57.5%
23 Cm2 (R) ACh 12 6.0 1.0% 58.5%
24 Tm12 (R) ACh 12 6.0 1.0% 59.5%
25 Tm2 (R) ACh 12 6.0 1.0% 60.4%
26 Tm5c (R) Glu 12 6.0 1.0% 61.4%
27 Dm13 (R) GABA 11 5.5 0.9% 62.3%
28 Dm8b (R) Glu 11 5.5 0.9% 63.2%
29 T1 (R) unclear 11 5.5 0.9% 64.0%
30 T4a (R) ACh 11 5.5 0.9% 64.9%
31 T4d (R) ACh 11 5.5 0.9% 65.8%
32 TmY14 (R) Glu 11 5.5 0.9% 66.7%
33 Cm3 (R) GABA 10 5.0 0.8% 67.5%
34 Cm5 (R) GABA 10 5.0 0.8% 68.3%
35 Pm10 (R) GABA 10 5.0 0.8% 69.1%
36 aMe3 (R) Glu 9 4.5 0.7% 69.8%
37 MeVPMe2 (R) Glu 9 4.5 0.7% 70.6%
38 Tm20 (R) ACh 9 4.5 0.7% 71.3%
39 Tm23 (R) GABA 9 4.5 0.7% 72.0%
40 Tm5b (R) ACh 9 4.5 0.7% 72.7%
41 TmY15 (R) GABA 9 4.5 0.7% 73.5%
42 Cm1 (R) ACh 8 4.0 0.6% 74.1%
43 Tm9 (R) ACh 8 4.0 0.6% 74.7%
44 Dm1 (R) Glu 7 3.5 0.6% 75.3%
45 Dm8a (R) Glu 7 3.5 0.6% 75.9%
46 TmY10 (R) ACh 7 3.5 0.6% 76.4%
47 aMe4 (R) ACh 6 3.0 0.5% 76.9%
48 Dm12 (R) Glu 6 3.0 0.5% 77.4%
49 DNc02 (R) unclear 6 3.0 0.5% 77.9%
50 MeTu3c (R) ACh 6 3.0 0.5% 78.4%
51 Mi1 (R) ACh 6 3.0 0.5% 78.8%
52 Mi19 (R) 5HT 6 3.0 0.5% 79.3%
53 Tm6 (R) ACh 6 3.0 0.5% 79.8%
54 Ascending_TBD1 (R) unclear 5 2.5 0.4% 80.2%
55 Cm35 (R) GABA 5 2.5 0.4% 80.6%
56 Cm8 (R) GABA 5 2.5 0.4% 81.0%
57 MeVPMe12 (R) ACh 5 2.5 0.4% 81.4%
58 Mi16 (R) GABA 5 2.5 0.4% 81.8%
59 Pm4 (R) GABA 5 2.5 0.4% 82.2%
60 TmY16 (R) Glu 5 2.5 0.4% 82.6%
61 Am1 (R) GABA 4 2.0 0.3% 82.9%
62 Cm11a (R) ACh 4 2.0 0.3% 83.3%
63 Cm31b (R) GABA 4 2.0 0.3% 83.6%
64 Dm9 (R) Glu 4 2.0 0.3% 83.9%
65 Li29 (R) GABA 4 2.0 0.3% 84.2%
66 LPLC1 (R) ACh 4 2.0 0.3% 84.6%
67 MeLo11 (R) Glu 4 2.0 0.3% 84.9%
68 MeLo7 (R) ACh 4 2.0 0.3% 85.2%
69 Mi10 (R) ACh 4 2.0 0.3% 85.5%
70 OA-AL2i2 (R) OA 4 2.0 0.3% 85.8%
71 Pm2a (R) GABA 4 2.0 0.3% 86.2%
72 Tm37 (R) Glu 4 2.0 0.3% 86.5%
73 C3 (R) GABA 3 1.5 0.2% 86.7%
74 Cm11b (R) ACh 3 1.5 0.2% 87.0%
75 Cm17 (R) GABA 3 1.5 0.2% 87.2%
76 Cm29 (R) GABA 3 1.5 0.2% 87.4%
77 Dm-DRA1 (R) Glu 3 1.5 0.2% 87.7%
78 Dm18 (R) GABA 3 1.5 0.2% 87.9%
79 DNp30 (L) unclear 3 1.5 0.2% 88.2%
80 l-LNv (R) unclear 3 1.5 0.2% 88.4%
81 L3 (R) ACh 3 1.5 0.2% 88.7%
82 LoVC21 (L) GABA 3 1.5 0.2% 88.9%
83 MeLo13 (R) Glu 3 1.5 0.2% 89.1%
84 MeLo6 (R) ACh 3 1.5 0.2% 89.4%
85 MeTu1 (R) ACh 3 1.5 0.2% 89.6%
86 MeVC22 (R) Glu 3 1.5 0.2% 89.9%
87 Mi20 (R) Glu 3 1.5 0.2% 90.1%
88 Pm7 (R) GABA 3 1.5 0.2% 90.3%
89 T2a (R) ACh 3 1.5 0.2% 90.6%
90 TmY19b (R) GABA 3 1.5 0.2% 90.8%
91 TmY5a (R) Glu 3 1.5 0.2% 91.1%
92 aMe12 (R) ACh 2 1.0 0.2% 91.2%
93 aMe17c (R) Glu 2 1.0 0.2% 91.4%
94 Cm20 (R) GABA 2 1.0 0.2% 91.6%
95 Cm31a (R) GABA 2 1.0 0.2% 91.7%
96 Cm4 (R) Glu 2 1.0 0.2% 91.9%
97 Dm4 (R) Glu 2 1.0 0.2% 92.0%
98 Lawf2 (R) ACh 2 1.0 0.2% 92.2%
99 LC4 (R) ACh 2 1.0 0.2% 92.4%
100 LT58 (R) Glu 2 1.0 0.2% 92.5%
101 MeLo1 (R) ACh 2 1.0 0.2% 92.7%
102 MeLo2 (R) ACh 2 1.0 0.2% 92.8%
103 MeLo4 (R) ACh 2 1.0 0.2% 93.0%
104 MeLo9 (R) Glu 2 1.0 0.2% 93.2%
105 MeVCMe1 (L) ACh 2 1.0 0.2% 93.3%
106 MeVP10 (R) ACh 2 1.0 0.2% 93.5%
107 MeVP51 (R) Glu 2 1.0 0.2% 93.6%
108 MeVP7 (R) ACh 2 1.0 0.2% 93.8%
109 MeVPLo1 (R) Glu 2 1.0 0.2% 94.0%
110 MeVPMe2 (L) Glu 2 1.0 0.2% 94.1%
111 Mi13 (R) Glu 2 1.0 0.2% 94.3%
112 Mi17 (R) GABA 2 1.0 0.2% 94.4%
113 Mi9 (R) Glu 2 1.0 0.2% 94.6%
114 OA-AL2i3 (R) OA 2 1.0 0.2% 94.8%
115 Pm3 (R) GABA 2 1.0 0.2% 94.9%
116 T3 (R) ACh 2 1.0 0.2% 95.1%
117 Tm36 (R) ACh 2 1.0 0.2% 95.3%
118 Tm39 (R) ACh 2 1.0 0.2% 95.4%
119 Tm5a (R) ACh 2 1.0 0.2% 95.6%
120 Tm5Y (R) ACh 2 1.0 0.2% 95.7%
121 Y3 (R) ACh 2 1.0 0.2% 95.9%